International Journal of Medical Informatics
Volume 77, Issue 6 , Pages 421-430 , June 2008

A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system

  • Yvonne Koh

      Affiliations

    • Department of Pharmacy, National University of Singapore, Republic of Singapore
    • ,
  • Chun Wei Yap

      Affiliations

    • Department of Pharmacy, National University of Singapore, Republic of Singapore
    • ,
  • Shu Chuen Li

      Affiliations

    • Department of Pharmacy, National University of Singapore, Republic of Singapore
    • Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Science, University of Newcastle, Australia
    • Corresponding Author InformationCorresponding author at: Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Science, University of Newcastle, Callaghan, NSW 2308, Australia. Tel.: +61 2 49215921; fax: +61 2 49212044.

Received 10 January 2007 ,Revised 3 June 2007 ,Accepted 19 August 2007.

References 

  1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. JAMA. 1995;274:29–34
  2. Leape LL, Bates DW, Cullen DJ, Cooper J, Demoncao HJ, Gallivan T, et al. Systems analysis of adverse drug events. JAMA. 1995;274:35–43
  3. Karch FE, Lasagna L. Adverse drug reactions—a critical review. JAMA. 1975;234:1236–1241
  4. Hannan T. Detecting adverse drug reactions to improve patient outcomes. Int. J. Med. Inf. 1999;55:61–64
  5. Stephens MDB. The Detection of New Adverse Drug Reactions. 2nd ed.. Basingstoke: The MacMillan Press; 1988;
  6. Backstrom M, Mjorndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol. Drug Saf. 2004;13:483–487
  7. Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration. J. Gen. Intern. Med. 2003;18:57–60
  8. Bousquet C, Henegar C, Louet AL, Degoulet P, Jaulent MC. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach. Int. J. Med. Inf. 2005;74:563–571
  9. Waller P, Heeley E, Moseley J. Impact analysis of signals detected from spontaneous adverse drug reaction reporting data. Drug Saf. 2005;28:843–850
  10. Naranjo CA, Shear NH, Lanctôt KL. Advances in the diagnosis of adverse drug reactions. J. Clin. Pharmacol. 1992;32:897–904
  11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probabilty of adverse drug reactions. Clin. Pharmacol. Ther. 1981;30:239–245
  12. Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions—a matter of opinion. Clin. Pharmacol. Ther. 1976;19:489–492
  13. Thiessard F, Roux E, Miremont-Salame G, Fourrier-Reglat A, Haramburu F, Tubert-Bitter P, et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986–2001). Drug Saf. 2005;28:731–740
  14. Lane DA, Kramer MS, Hutchinson TA, Jones JK, Naranjo CA. The causality assessment of adverse drug reactions using a Bayesian approach. Pharm. Med. 1987;2:265–283
  15. Koh Y, Li SC. A new algorithm to identify the causality of adverse drug reactions. Drug Saf. 2005;28:1159–1161
  16. Lucasius CB, Kateman G. Understanding and using genetic algorithms. Part 1. Concepts, properties and context. Chemom. Intell. Lab. Syst. 1993;19:1–33
  17. Heckerling P, Canaris G, Flach S, Tape T, Wigton R, Gerber B. Predictors of urinary tract infection based on artificial neural networks and genetic algorithms. Int. J. Med. Inf. 2007;76:289–296
  18. Vinterbo S, Ohno-Machado L. A genetic algorithm approach to multi-disorder diagnosis. Artif. Intell. Med. 2000;18:117–132
  19. Cotrutz C, Xing. L. Segment-based dose optimization using a genetic algorithm. Phys. Med. Biol. 2003;48:2987–2998
  20. Podgorelec V, Brest J, Kokol P. Power of heterogeneous computing as a vehicle for implementing E(3) medical decision support systems. Int. J. Med. Inf. 2000;58/59:179–190
  21. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description adn instructins for use. JAMA. 1979;242:623–632
  22. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin. Pharmacol. Ther. 1977;21:247–254
  23. Jones JK. Adverse drug reaction in the community health setting: approaches to recognizing, counseling and reporting. Fam. Community Health. 1982;5:58–67
  24. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie. 1985;40:115–118
  25. Mashford ML. The Australian method of drug event assessment. Drug Inf. J. 1984;18:271–273
  26. WHO-UMC Causality Assessment System [last visited July 16, 2004]; available from: http://www.who-umc.org/pdfs/Causality.pdf.
  27. SPSS for Windows, Rel. 12.0.0, SPSS Inc., Chicago, 2003.

PII: S1386-5056(07)00163-3

doi: 10.1016/j.ijmedinf.2007.08.010

International Journal of Medical Informatics
Volume 77, Issue 6 , Pages 421-430 , June 2008

Article Tools

* Image Usage & Resolution